Clinical Trial Update: Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating hetrombopag for chemotherapy-induced thrombocytopenia in patients with malignancy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Chemotherapy-Induced Thrombocytopenia | Phase 3 | Status: COMPLETED